Evidence map›Paper›PMID 38034823›Full record

ArticleFrontiers in pediatrics2023

High number of seizures and unconsciousness in patients with SARS-CoV-2 omicron variants: a retrospective study.

Kishin Tokuyama, Tsubasa Kitamura, Kazutaka Maruyama, Shun Toriumi, Yayoi Murano, Daisuke Yoneoka, Tomoyuki Nakazawa, Toshiaki Shimizu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pediatrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. [Gastrointestinal manifestations and liver disorders in patients with COVID-19].Revista medica del Instituto Mexicano del Seguro Social · 2024
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Kishin TokuyamaDivision of Pediatrics, Tokyo Metropolitan Toshima Hospital, Tokyo, Japan.
Tsubasa KitamuraDivision of Pediatrics, Tokyo Metropolitan Toshima Hospital, Tokyo, Japan.
Kazutaka MaruyamaDivision of Pediatrics, Tokyo Metropolitan Toshima Hospital, Tokyo, Japan.
Shun ToriumiDivision of Pediatrics, Tokyo Metropolitan Toshima Hospital, Tokyo, Japan.
Yayoi MuranoDivision of Pediatrics, Tokyo Metropolitan Toshima Hospital, Tokyo, Japan.
Daisuke YoneokaCenter for Surveillance, Immunization, and Epidemiologic Research, National Center of Infectious Disease, Tokyo, Japan.
Tomoyuki NakazawaDivision of Pediatrics, Tokyo Metropolitan Toshima Hospital, Tokyo, Japan.
Toshiaki ShimizuDepartment of Pediatrics, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Juntendo University · JPToshima Hospital · JPNational Institute of Infectious Diseases · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron variants are now a pandemic. There are differences in clinical features in SARS-CoV-2 variants and we conducted this study to assess the clinical features of coronavirus disease (COVID-19) in children with SARS-CoV-2 omicron variants. The study included children with COVID-19 arrivedto Tokyo Metropolitan Toshima Hospital between January 2020 and October 2022. The clinical features of 214 children with SARS-CoV-2 non-omicron variants and 557 children with omicron variants were compared. In the SARS-CoV-2 omicron variant group, more patients had fever, sore throat, nausea and/or vomiting, and seizures and/or disorders of consciousness. In SARS-CoV-2 non-omicron variants, there was only one patient with seizure and/or unconsciousness whereas there were 92 children in omicron variants. Among these 92 patients, 46 (49%) were diagnosed with simple febrile seizures; 23 (25%), with complex febrile seizures; 10 (11%) with status epilepticus; and two (2%) with encephalopathy. Their mean age was 4.0 ± 3.0 years-a wider age distribution than that in other febrile seizures but similar to that in febrile seizures in patients with influenza. SARS-CoV-2 omicron variants are likely to cause seizures and unconsciousness in children and their age distribution was wider than other febrile seizures patients but similar to those in influenza patients. In clinical practice in patients with COVID-19 and influenza, clinicians should be aware of these features.

Indexed as

COVID-19febrile seizureomicron variantsSARS-CoV-2seizure

Identifiers

PMID38034823
PMCPMC10684743
OpenAlexW4388717191

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.